Transcription of Annex 9 - WHO
{{id}} {{{paragraph}}}
Example: biology
Annex 9 - WHO
439 World Health OrganizationWHO Technical Report Series, No. 937, 2006 Annex 9 Additional guidance for organizations performing in vivo bioequivalence studiesIntroduction1. Scope2. Glossary 3. Organization and management 4. Computer systems Hardware Software Data management 5. Archive facilities 6. Premises 7. Clinical phase 8. Clinical laboratory 9. Personnel 10. Quality assurance 11. Ethics Independent ethics committee Informed consent 12. Monitoring 13. Investigators 14. Receiving, storage and handling of investigational drug products15.
441 Bioequivalence studies should be performed in compliance with the general regulatory requirements and recommendations on good practices as speci-
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: